The Evaluation of Pharmacologic Agents on Composite Graft Survival

Kenneth K. Aden, Merrill A. Biel

Research output: Contribution to journalArticlepeer-review

32 Scopus citations


This study assessed the efficacy of various pharmacologic agents in improving composite graft viability in 60 New Zealand white rabbits given bilateral auricular composite grafts. Treatments included methylprednisolone preoperatively and for 3 days postoperatively or for 7 days postoperatively only; chlorpromazine, dimethylsulfoxide, or superoxide dismutase preoperatively; or indomethacin preoperatively and for either 3 or 7 days postoperatively. Four treatment modalities yielded a statistically significant decrease in percentage of necrosis. Methylprednisolone, when given preoperatively and continued postoperatively, produced the greatest increase (77%) in composite graft tissue survival. Dimethylsulfoxide, chlorpromazine, and indomethacin for 3 days were also effective, but to a much lesser extent. It is speculated that these agents may help stabilize cell membranes during the anoxic phase of plasmic imbibition and minimize cellular edema until revascularization can occur.

Original languageEnglish (US)
Pages (from-to)175-178
Number of pages4
JournalArchives of Otolaryngology--Head and Neck Surgery
Issue number2
StatePublished - Feb 1992

Bibliographical note

Copyright 2015 Elsevier B.V., All rights reserved.


Dive into the research topics of 'The Evaluation of Pharmacologic Agents on Composite Graft Survival'. Together they form a unique fingerprint.

Cite this